PTAB
IPR2017-01526
Mylan Pharmaceuticals Inc v. Sanofi Aventis Deutschland GmbH
General
Institution12/13/17
FWD--
Close12/12/18
StatusFinal Written Decision
OutcomeUnpatentable
USPTOIPR2017-01526
Appeals
Administrative Patent Judges
Judge | Cases | Inst. Rate | FWD Inv. Rate |
|---|---|---|---|
| Erica A Franklin | 400+ | 53% | 69% |
| Michelle N Ankenbrand | 200+ | 48% | 80% |
| Roberta Pollock | 400+ | 67% | 67% |
Petitioner
Attorney
Name | Ratings |
|---|---|
L5 B | |
L5 A | |
L3 B | |
-- -- -- | |
-- -- -- | |
-- -- -- | |
-- -- -- |
No Attorneys
Respondent